Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Medical Marijuana: A Potential Treatment for Alzheimer’s?

By Meg Snyder | July 27, 2016

One study has found that medical marijuana could potentially be used as a treatment for Alzheimer’s disease. 

According to a study published in npj Aging and Mechanisms of Disease, tetrahydrocannabinol (THC), the psychoactive ingredient in cannabis, assists in the removal of toxic plaque in the brain, which is a common symptom of the disease. 

“Cannabinoids such as tetrahydrocannabinol [THC] stimulate the removal of intraneuronal Aβ [beta amyloid], block the inflammatory response, and are protective,” researchers reported. By blocking inflammation, THC helps to prevent damages to the neurons in the brain. 

Although these results have sparked further curiosities in the industry, many professionals say that the theory isn’t ready to be tested on patients. 

An article in CNN says that “[w]hile easing the complaints of patients is helpful, scientists hope for something much more out of marijuana and all other avenues of research—namely, a preventative treatment or even a cure for Alzheimer’s.”

At present, no effective therapies for stopping Alzheimer’s and other neurodegenerative conditions have been found.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news! 


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE